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Abstract
Background: Current research shows that overall numbers for cannabis use among adolescents and young
adults dropped in recent years. However, this trend is much less pronounced in continuous cannabis use. With
regard to the heightened risk for detrimental health- and development-related outcomes, adolescents and
young adults with continuous cannabis use need special attention. The health services structure for adolescents
and young adults with substance related problems in Germany, is multifaceted, because different communal,
medical and judicial agencies are involved. This results in a rather decentralized organizational structure of the
help system. This and further system-inherent characteristics make the threshold for young cannabis users rather
high. Because of this, there is a need to establish evidence-based low-threshold help options for young
cannabis users, which can be easily disseminated. Therefore, a training programme for young cannabis users
(age 14-21) was developed in the “CAN Stop” project. Within the project, we seek to implement and evaluate
the training programme within different institutions of the help system. The evaluation is sensitive to the
different help systems and their specific prerequisites. Moreover, within this study, we also test the practicability
of a training provision through laypersons.
Methods/Design: The CAN Stop study is a four-armed randomized wait-list controlled trial. The four arms are
needed for the different help system settings, in which the CAN Stop training programme is evaluated: (a) the
drug addiction aid and youth welfare system, (b) the out-patient medical system, (c) the in-patient medical system
and (d) prisons for juvenile offenders. Data are collected at three points, before and after the training or a
treatment as usual, and six months after the end of either intervention.
Discussion: The CAN Stop study is expected to provide an evidence-based programme for young cannabis users
seeking to reduce or quit their cannabis use. Moreover, we seek to gain knowledge about the programme’s utility
within different settings of the German help system for young cannabis users and information about the settings’
specific clientele. The study protocol is discussed with regard to potential difficulties within the different settings.
Trial registration: ISRCTN: ISRCTN57036983
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In 2008, the lifetime prevalence of cannabis use among
German adolescents and young adults between age 12
and 25 of 28.3% dropped for the first time after a con-
tinuous rise throughout previous years (1997: 18.9%;
2001: 25.6%; 2004: 31.1%) [1]. This trend was confirmed
by another large study throughout various European
countries and North America in a survey of adolescents
and their cannabis use over the past 12 months [2].
12.8% of 15 year old boys and 10.2% of 15 year old girls
reported having used cannabis at least once in the past
12 months in 2006, while rates in 2002 were higher for
boys (22.3%) and girls (14.9%). These data, however,
include occasional use of cannabis. Rates of a continu-
ous use of cannabis, defined as more than ten occasions
of cannabis use per year, also decreased in German 12
to 25 year-olds in 2008, yet the decrease was less pro-
nounced and the prevalence of 2.3% [1] still shows, that
continuous cannabis use remains a striking phenom-
enon among German adolescents and young adults.
Cannabis use is known to be associated with various
psychosocial problems and negative outcomes for con-
sumers. Best, Gross, Manning, Gossop, Witton and
Strang [3] showed that adolescent cannabis users (age
14-16) spent more time with peers, who were involved
in criminal activities and/or consumed cannabis and
other substances (tobacco, alcohol and illicit drugs),
while spending less time with parents. These phenom-
e n at e n d e dt ob em o r ep r o n o u n c e dw h e na d o l e s c e n t s
initiated their cannabis use early within their life-span.
Similar results were found by Flory, Lynam, Milich, Leu-
kefeld and Clayton [4], who reported of a higher likeli-
hood for getting arrested or showing symptoms of
alcohol misuse or dependence and antisocial personality
disorder among cannabis users. Once more, early-onset
cannabis users were found to be at greater risk. In addi-
tion, marijuana users reported lower self-esteem, poorer
family relations and peer pressure resistance than non-
consuming controls. Poorer educational attainment was
another negative outcome of adolescent and young adult
marijuana users [5]. Adolescent drug and cannabis use
was also linked to a less successful autonomy develop-
ment and diminished perceived competences later in life
[6]. Moreover, the strain for affected family members -
especially parents - can be considerable when adolescent
marijuana use becomes a habit in the family [7].
In addition, adolescent cannabis use was shown to be
linked to psychiatric disorders. For once, marijuana use
itself can result in cannabis misuse (ICD-10: F12.1) or
dependence (ICD-10: F12.2). The existence of a physical
withdrawal syndrome after marijuana detoxification is
established among scientists [8]. Moreover, persons with
a genetic risk for psychotic disorders tend to get
diagnosed more often and earlier, after using marijuana.
Other disorders, which are in discussion about being
associated with cannabis use are depressive and anxiety
disorders. Overall estimates of comorbid mental health
problems are assumed to range as high as 70% in mari-
juana addicts [9]. Interestingly, high marijuana use pat-
terns do not seem to be a necessary prerequisite for
later mental health problems. Windle and Wiesner [5]
already found elevated rates of anxiety disorders and
major depression in young adults who reported “only”
an experimental use of marijuana in their adolescence
as compared to abstainers. In sum, mental health pro-
blems seem to be closely associated with both, experi-
mental and continuous marijuana use. The timely
sequence of marijuana use and other mental health pro-
blems is not fully understood yet, and therefore infer-
ences about causal patterns can not be adequately
substantiated. Evidence exists, that persons suffering
from mental health problems may use cannabis as a
means to regulate their emotions. On the other hand,
m a r i j u a n au s ei sk n o w nt ob ea b l et ot r i g g e re . g .p a n i c
attacks. Right now, multifactorial etiological models are
used to explain the association between marijuana use
and the various psychosocial and health-related out-
comes. With regard to the multiple dysfunctional out-
comes and health-risks, interventions are needed to
reduce cannabis use and abuse in adolescents and
young adults.
In Germany, the support system for drug- and addic-
tion-related health problems consists of different institu-
tions. The majority of institutions supporting individuals
with drug-related problems belongs to the so-called
addiction aid (Suchthilfe). Institutions of this kind are
all supervised and funded by the communities (Kommu-
nen). Mostly support is provided by independent welfare
institutions, which receive their funding by the munici-
pality and through private donations and which report
to the local authorities. A broad network of these insti-
tutions exists mostly in the form of walk-in counselling
facilities. Some in-patient projects exist, which provide
e.g. accommodation and a pedagogic support system for
long-term heavy drug users. The professional back-
ground among the staff varies ranging from social wel-
fare workers, education specialists, psychologists,
psychotherapists and nurses to physicians. As a result of
this non-centralized set-up, a multitude of different
approaches and concepts exists on how to deliver sup-
port for drug users. This enables communities to shape
their support service alongside the specific needs of the
municipality (e.g. with regard to their urban or rural
backgrounds and related specific drug use patterns), yet,
a lot of networking among different institutions is
necessary to provide for an efficient exchange between
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(e.g. legal authorities, police).
Individuals with drug-related problems may also
approach the medical system for help. Costs for these
services are covered by either private or public health
insurances. All but 0.2% of Germans are covered by one
of this kind of health insurances [10]. For out-patient
support, a broad network of general practitioners and
pediatrists exists, which either provide help themselves
or refer patients to specialists such as psychiatrists, child
and adolescent psychiatrists and psychotherapists.
Patients can also choose to consult these specialists
directly if they wish to. Some larger clinics also provide
out-patient walk-in clinics for patients with mental
health problems. Yet, only a few are specialized in treat-
ment of adolescent and young adult drug abuse. For
patients with a bigger need for help, day-clinics exist,
with a psychiatric or child and adolescent psychiatric
background. There too, mental health problems can be
treated, however, again, specialized services to tackle
substance abuse in concordance with other mental
health problems are scarce and often, abstinence from
drugs is a prerequisite for admission.
In-patient services for adolescent and young adult
drug users are provided by psychiatric and child and
adolescent psychiatric clinics. One of their main foci is
to provide withdrawal treatment under medical supervi-
sion. Another task is to initiate a psychotherapeutic
treatment after detoxification. Again, only few in-patient
clinics exist with a specialized focus on drug using ado-
lescents on own wards and concepts to combine with-
drawal with subsequent psychotherapeutic treatment.
Within the medical system, medical rehabilitation clinics
stand out as a specialized agent of health care provision
for patients with chronic diseases, among which drug
abuse and addiction are also subsumed. Their main
focus is to ensure the return of the chronically ill into
the labour force. They are funded mainly through social
pension insurance providers, less often by health insur-
ances. Although adolescents may also be treated within
the medical rehabilitation system for the chronically ill,
specialized care regarding drug abuse or addiction exists
only for individuals older than 17 years.
In sum, there are various institutions in Germany pro-
viding help for adolescents and young adults with mari-
juana abuse. Recently, the demand for help for this
target group has been on the rise. Between 1999 and
2005, persons, who were seeking treatment for canna-
bis-related disorders, tripled in Europe [11]. The same
trend was reported for Germany, where numbers of cli-
ents in out-patient counselling facilities, who named
cannabis use as their main problem rose drastically [12]
in the early 2000er years. As the number of continuous
cannabis users still is rather high, this need is expected
to continue. However, service and treatment provision
for this special group turned out to be difficult for a
number of reasons. A lot of walk-in counselling facil-
ities, usually serving as the first contact point for per-
sons seeking professional help, faced a sudden change
during the early 2000es. With the rise of cannabis users,
the age of help-seeking clients dropped. More than
before, parents of affected teenagers sought help in
walk-in counselling facilities. As a consequence, the pro-
file of counselling facilities had to change with the new
demand. Yet, experience was missing and help-seeking
clients were partly deterred from existing counselling
facilities. Clients did not feel they were in the right
hands as traditional facilities carried the atmosphere of
the traditional drug scene and its tendency to pauperiza-
tion. To lower the threshold for possible new clients
with cannabis-related problems, steps were initiated to
link the facilities of the traditional addiction aid with
facilities of the youth welfare context, a support system
which for example run youth clubs, but previously iden-
tified not very much with the topic [13]. As an example,
the City of Hamburg in 2006 opened five new walk-in
counselling facilities with a special focus on adolescent
substance use problems and started to link both addic-
tion aid and youth welfare facilities in an innovative pro-
ject. However, through the de-centralized set-up of the
help system for young cannabis users in Germany, these
kinds of initiatives remain up to local authorities and
mostly do not base on guidelines developed by experts
or on an evidence-based level. Still, the problem of get-
ting access to young cannabis users with existing struc-
tures was identified by Federal agencies, which funded
expertises on the problem [14].
With regard to the medical system, help-seeking ado-
lescent and young adult cannabis users seemed to be
rather reluctant to get counselling by physicians and
psychotherapists. As described earlier, competent help
could be given in the psychiatric and child and adoles-
cent psychiatric field, however, this label seemed to
deter both adolescents and their parents and young
adults alike. Specialized out-patient clinics within the
medical system, who manage to develop a tailored
address to young cannabis users are rather limited and
are difficult to reach for potential patients, especially in
rural contexts. This is even more so, when motivation
of patients is rather low. This, however, often is the case
in cannabis users [14], who frequently show a limited
awareness of their problem and a lack of drive. Conse-
quently, the threshold to utilize services of the medical
system is high and incoming patients are mostly those
with protracted abuse histories.
In sum, with regard to the different institutions,
which provide professional assistance for cannabis
using adolescents and young adults, there are a
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challenge with the new group of help-seekers and have
to respond to this demand rather quickly. Moreover,
system-inherent conditions set the threshold for ser-
vice utilization rather high.
Several efforts are made to rise to this challenge
through several federally funded model-projects. Within
these, standardized counselling and treatment pro-
grammes were developed or adapted and evaluated to
provide for evidence-based offers. In the following, some
of these projects will be introduced. The project CAN-
DIS [15] refers to cannabis using patients 16 year old or
older and encompasses ten psychotherapeutic single-cli-
ent sessions with a cognitive behavioural therapeutic
approach. First results are being published and evalua-
tion was extended from a university-based psychological
research centre to eleven walk-in counselling facilities.
Treatment is delivered by specially trained psychologists.
The project INCANT adapted the multidimensional
family therapy programme of Liddle and his research
group [16] and combines family therapy with adolescent
psychotherapeutic approaches. It is currently being eval-
uated in selected counselling facilities and comprises
the whole family system of cannabis using clients aged
13 to 18.
Another programme, which was particularly developed
for cannabis users (age 15 to 30), is named “Realize it!”
and consists of several single- and group-counselling
sessions. After a first evaluation in southern Germany
and Switzerland, it is now extended to other walk-in
counselling facilities in Germany [17]. FReD is a coun-
selling programme, which is not tailored for cannabis
users alone, but refers to persons aged 14 to 21, who
got into legal conflicts with the police because of drug
related offence and get invited to the programme as a
consequence of their police record. Mirroring the nature
of this concept, male participants of the programme are
overrepresented. The programme encompasses eight
group sessions and deals with drug-related problems as
well as legal advice. An evaluation of the programme
was undertaken [18] and the programme was finished
its model phase in 2007 and is currently implemented at
about 140 locations in Germany. “Quit the shit” is an
internet-based counselling offer for adolescents and
young adults with cannabis use problems. It comprises
an online substance use diary and feedback from trained
professionals (http://www.drugcom.de/bot_quittheshit.
html) through chats. The approach to adolescent and
young adult cannabis users turned out to be well-
accepted. But researchers pointed out that it serves
rather as a first step for cannabis users who seek help
and may be inappropriate for aggravated consume pat-
terns or cannabis users with additional mental health
problems [19].
With the previously mentioned programmes on the
agenda, however, several needs for the provision of com-
prehensive care for adolescent and young adult cannabis
users remain unmet. So far, programmes with a specific
focus on cannabis for adolescents and young adults are
scarce, and existing programmes tend to rely on psy-
chotherapeutically trained personnel or certain profes-
sional groups. Yet, these prerequisites for personnel are
often not met by service providers, or they are not met
in a sufficient number of existing staff members to face
t h er a t h e rh i g hp r e v a l e n c eo f help-seekers. With this
regard, specific group-based offers seemed to be missing.
Another setting, in which systematic service provision
beyond basic structural drug prevention efforts (e.g.
general drug use ban etc.) for adolescent and young
adult cannabis users is nearly entirely missing, is the
juvenile penal system [20]. In Germany, juvenile prisons
encompass persons aged 14 to 25 who were convicted
under juvenile criminal law. Among the approximately
6500 mostly male young offenders, who are currently
serving their prison sentence in Germany, nearly all
have experiences with addictive drugs and 60% of
incoming juvenile offenders report having used illicit
drugs within the past four weeks before serving the
prison sentence [21]. Among illicit drugs, cannabis is
the most important problem drug [22] and although of
course, cannabis use within juvenile prisons is strictly
prohibited, ongoing consumption of cannabis takes
place. Up to date, we know of no manualized or evi-
dence-based support programme to address cannabis
misuse or dependence in adolescent or young adult
offenders serving their prison sentence.
In order to fill the described gaps in the support sys-
tem for cannabis using adolescents and young adults,
our research group developed a structured, manualized
group training programme “CAN Stop”, which focuses
on this specific target group between age 14 and 21,
whose needs so far have not been adequately met by the
various support system components. The first goal of
the project is to provide for an evaluated, evidence-
based group programme, which can be easily dissemi-
nated and which is tailored to the developmental char-
acteristics and contexts of adolescents and young adults.
We hypothesize that young cannabis users who partici-
pated at the CAN Stop group training in addition to the
treatment or service usually provided in the specific
help provision context (e.g. drug addiction aid and
youth welfare, in-patient medical context, out-patient
medical context, juvenile prisons) show lower level of
cannabis intake and higher levels of cannabis absti-
nence-related self-efficacy after the training as opposed
to young cannabis users who received the usual treat-
ment or service. As for the implementation of the pro-
gramme, we are aware of the existing subdivided and at
Baldus et al. BMC Health Services Research 2011, 11:80
http://www.biomedcentral.com/1472-6963/11/80
Page 4 of 10times confusing help provision system for young canna-
bis users in Germany, and we believe it is inherent for
the effectiveness and for the future dissemination and
practicability of the programme, that it is tried out
within these different help provision settings. We
hypothesize, that because of their above mentioned
structural and organizational characteristics, different
clientele and context-specific staff will be met within
these settings. That is why the programme is implemen-
ted and evaluated separately in four different settings (a)
the drug addiction aid and youth welfare system, (b) the
out-patient medical system, (c) the in-patient medical
system and (d) prisons for juvenile offenders. This offers
the possibility to check for the suitability of the pro-
gramme in different settings - our second goal - and to
compare its effectiveness and utility within them. Our
third goal is to draw conclusions for the future imple-
mentation of the CAN Stop training in different help
provision settings. Moreover, our fourth goal is to gain
knowledge about the incoming clientele of the different
settings with regard to their substance use patterns,
severity of dependence, psychosocial adjustment,
expected effects of cannabis use and family and peer
relations. As for the realization of the training pro-
gramme, this remains in the hand of the existing staff of
the different settings. A novelty of the programme is,
that no specific prerequisites are prescribed as to the
professional background or existing (therapeutic) experi-
ence of the trainers. The only exception is the staffs’
contact with cannabis using adolescents and young
adults as part of their occupation within one of the
above mentioned settings and a basic interest to realize
the training. This approach may include staff from
prison guards, to ex-users working in the addiction aid
system to psychotherapists and medical doctors and
nurses. With this approach, the introduced study not
only evaluates the effectiveness of a group training pro-
gramme for cannabis using adolescents and young
adults (14-21) but also evaluates the instructions given
to the trainers, who perform the actual training with the
target group, in form of a course of instruction and a
newly developed manual. The fifth goal of the project is
to evaluate the CAN stop group training programme
with regard to its gender-specific utility and effective-
ness. Previous therapeutic approaches were evaluated
with largely male samples. This may in part be due to
the higher prevalences of male cannabis users, but may
to some extent also lie in the fact, that previous pro-
grammes and approaches were more shaped to address
males and were not equally fit to address the specific
needs of female cannabis users. The CAN Stop group
training was explicitly developed to meet both male and
female young cannabis users’ needs in that it for exam-
ple also refers to accompanying internalizing problems
and the importance of the dynamics of a romantic part-
nership with cannabis use patterns - topics which are
deemed to address especially female young cannabis
users.
Methods/Design
Study Design and Setting
The CAN Stop study is a four-armed randomized wait-
list controlled trial. Following Zwarenstein et al.’s[ 2 3 ]
theoretical continuum of evaluation trials, on which
rather “experimental”, explanatory efficacy-oriented
trials form the one end, and naturalistic, pragmatic
effectiveness-oriented trials form the other end, this
study tends towards the latter, pragmatic end. Develo-
pers were more interested in the real-life utility of the
CAN Stop group training within the described four dif-
ferent contexts with their aforementioned specificities.
Data will be gathered at three points: before the group
training (pre), after the group training (post; 3 months
after pre) and at a follow-up (6 months after post).
Modes of data retrieval vary from face-to-face interviews
and questionnaires (pre), to questionnaires only (post)
and telephone interviews and questionnaires (follow-up).
Group comparisons will be made to check for the group
training’s effectiveness.
Recruitment of cooperation partners and young cannabis
users
Subjects for the study are recruited by cooperating insti-
tutions from the settings mentioned above. These coop-
eration partners were trained by the study group to
identify incoming clientele for their eligibility to partici-
pate at the study, to perform motivating take-in talks to
these young cannabis users, and to gather data for the
first two points of measurement (pre and post). The fol-
low-up measurement will be performed by the study
group. Moreover, staff of the cooperation partners is
instructed to perform the CAN Stop training.
In a first attempt to identify suitable cooperation part-
ners, we systematically scanned comprehensive help
provision and therapy guides of Northern and Eastern
Germany as well as the Internet for institutions. All
identified institutions were then invited to participate at
the study with an information letter and asked to fax
back an attached reply form together with a question-
naire about structural and work details of the institu-
tion, such as number of incoming young cannabis users
in the targeted age range and number of staff. Prior to
this, a target number of cooperation partners needed to
gather the subjects was calculated on the basis of a
power calculation, an estimated attrition rate of 50%
and under the premise that CAN Stop training groups
should be composed of six to ten group participants. If
feedback was not given within six weeks after letters
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back with the institution. An exception from this proce-
dure was made within the setting of juvenile prisons:
because their total number was rather low, their staffs
were contacted directly via phone calls. The response
rate varied between different settings between 57% in
juvenile prisons, 10% in in-patient medical clinics, 5% in
out-patient medical clinics and 5% in the youth welfare
and drug addiction aid. If institutions signalled to be in
contact with young cannabis users in their daily routines
and were interested in study participatioin, a study
group member gave a presentation of the project and
invited institutions to participate at the study. In sum,
we could aquire a total of 11 cooperation partners
within the youth welfare and drug addiction aid, 9 coop-
eration partners of the out-patient medical system, 8
cooperation partners of the in-patient medical system
and 3 participating prisons for juvenile offenders. Parti-
cipating cooperation partners were randomly assigned
to perform the CAN Stop intervention plus their usual
treatment as an intervention group or to provide for
control group subjects, who received the cooperation
partner’s previously installed treatment as usual (TAU).
As for other treatments, provided by the different insti-
tutions (besides CAN Stop), cooperation partners dif-
fered in their usually provided routines depending on
their specific setting. While most prisons indicated,
other kinds of therapy besides CAN Stop were rather
limited and merely consisted of counselling talks or con-
ceptual work within the organizational framework of the
prison, the in-patient medical system’s cooperation part-
ners of course provided many other facets of treatment
- to mention both extremes of this varying continuum.
Institutions, which indicated they were already partici-
pating in other structured programmes similar to CAN
Stop were excluded from the study in order not to com-
pare CAN Stop with eventually competing studies (e.g.
FrED, see above).
Recruitment for subjects was performed by coopera-
tion partners within their daily work routines. In addi-
tion, the study group provided for flyers, which gave
information on the study, its objectives and the group
training to recruit participants. Young cannabis users
interested in the programme were asked to contact a
centralized telephone hotline installed by the study
group to provide for a first check-up of inclusion cri-
teria, to inform about the study and then to randomly
allocate subjects to wait list control groups or to inter-
vention groups in respective institutions. Young canna-
bis users in prisons are exempted from this procedure,
because a random allocation of prisoners is not possible:
the juidical allocation of young offenders into the pris-
ons will decide about whether they are selected into a
prison performing an intervention or a control group,
their inclusion criteria are checked in in-take talks.
Inclusion criteria were (1) the participants’ age between
14 and 21 years, (2) a cannabis consume, which is
deemed problematic by the young cannabis user or sig-
nificant persons in his or her context (e.g. parents, tea-
chers) (3) the participant’s willingness to at least think
over previous consumption patterns and to participate
at a group dealing with the topic and (4) the informed
consent of participants and in the case of underage par-
ticipants the informed consent of a parent or official
guardian. Young cannabis users were excluded from the
study when they showed acute symptoms of psychosis
or suicidality. Both of these exclusion criteria were
checked via standardized screening questions at the
beginning of the face-to-face take-in talks at the respec-
tive cooperation partner’s institutions. Young cannabis
users were invited to participate at the study regardless
of whether their access to cooperating institutions was
initiated by the cannabis users themselves or whether
pressure was exerted by e.g. school, employers or
because of a judicial condition of probation, however,
this is documented and will be integrated into outcome
analyses.
Both, staff from the cooperating institutions and study
participants received incentives for their efforts or taking
part in the study, respectively. Data gathering for pre
and post measurement by a staff member of the coop-
eration partner is awarded 10€,t h ep e r f o r m a n c eo fa
complete training cycle is compensated with 400€.
Young cannabis users receive 10€ for the completion of
the pre measurement, 25€ for the completion of the
post measurement and 50€ for the completion of a fol-
low-up measurement. Ethical questions arose, whether it
is suitable to give out cash to young cannabis users,
given the possibility that the money is spent for canna-
bis. However, we deemed the sum of the incentives for
young cannabis users small enough to be compared
with money, adolescents and young adults handle in
their daily routines and therefore argued that no addi-
tional allurement is attached to the incentives. More-
over, previous research with our institution had shown,
that cash incentives were more potent and appealing for
study subjects (Ravens-Sieberer, personal communica-
tion). If cooperation partners severely objected to this
procedure, however, we left the ultimate decision about
the nature of incentives to their staff and instructed
them to give out gift vouchers e.g. for local music stores
instead.
Intervention: The CAN Stop group training
The CAN Stop group training consists of eight group
sessions à 90 minutes. Groups consist of six to ten
young cannabis users and one or two trainers. The
group contents and its timeline is described in a detailed
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manual provides trainers with background knowledge
about cannabis, its effects, aspects of group dynamic as
well as recommendations regarding the trainer’s attitude
towards participants and their consumption. The train-
ing’s rationale is based on behavioural therapeutic and
motivational interviewing elements [24]. It encompasses
consumer or craving diaries, the work with social and
emotional context variables and potential triggers as
well as the elaboration of alternative behaviour strategies
and the activation of participants’ resources. Generally
and for motivational reasons, it is left open to partici-
pants within the training whether they want to reduce
or stop their cannabis use. However, certain settings at
which the training is tested officially require absolute
consume stops (e.g. prisons), yet this is a characteristic
of the respective institution and not of the training itself.
A more detailed description of the training is in pre-
paration. After completing the CAN Stop training, certi-
ficates are handed out to participants who, participated
a tl e a s ta tf i v eo u to fe i g h tg r o u pt r a i n i n gs e s s i o n s ,f o r
further gratification. If within a group, only three or less
participants remain after other participants dropped out
of the group, the group is not further continued.
Training of CAN Stop trainers
The CAN Stop training is performed by cooperation
partners’ staff. Their professional background may vary
starkly with regard to their therapeutical expertise. In
order to empower cooperation partners’ staff for per-
forming the training, motivating take-in talks and proce-
dures for data gathering, a detailed training is set up,
which every trainer has to undergo beforehand. As an
effect, our study’s goal in essence is, not only to test the
effect of the CAN Stop training but also to test the
approach to empower cooperations partners’ staff to
perform the training. Several measures are taken to pro-
vide for a sufficient quality assurance with regard to the
provision of the CAN Stop training. CAN Stop trainers
are asked to record each session on videotape. Video-
tapes will later be used to check for trainers’ adherence
to the manual. A special adherence measure was devel-
oped, which is oriented closely to the training contents
of each session. Regular supervision phone calls with
t r a i n e r sa r em a d eb yt h es t u d yg r o u pt oe n s u r et r a i n e r s
feel comfortable with their CAN Stop training delivery,
and trainers are invited to phone the study group if
questions arise, be it regarding contents or regarding
difficult social situations within the training or when
training participants show signs of acute psychosis or
suicidality. Notes are taken of these supervision talks for
later qualitative analyses. Identification of these pro-
blems and recommendations about how to deal with
them are also part of the training of trainers. For further
control with regard to the young cannabis users, partici-
pants’ comfort with the training, participants are asked
to indicate their mood shortly at the beginning and end
of each training sessions with colour-coded cards. More-
over, participants give feedback on the respective session
at the end of each CAN Stop training session with
regard to their satisfaction with the training contents
and the atmosphere in the group. These data will be
gathered and monitored by the study group to ensure
that no CAN Stop training runs out of hand.
Measures
Young cannabis users participating at the study were
asked to fill in several measures to assess target vari-
ables. Table 1 gives an overview of measures used.
In addition, trainers were asked to answer a short
questionnaire about themselves prior to t0 in order to
gather data for analysing possible trainer effects in sec-
ondary analyses. This included their professional back-
ground, own beliefs and attitudes towards cannabis use
and personality characteristics, using the Big Five Inven-
tory-10 (BFI-10) [25].
Measures against bias
The study is unblinded with regard to trainers, who
hand out the questionnaires at t0 and t1 measurements
to the clients. However, t2 telephone interviewers are
blind to whether participants belonged to a control or
intervention group. A problem of the study may be dif-
ferent selection effects in the groups. Participants of the
study may be inclined to follow through a regular train-
ing as opposed to potentially less structured treatment
as usual. In order to estimate this kind of bias we will
analyze models to predict drop-outs in both, the inter-
vention and the control group. In order to prevent trai-
ners from using CAN Stop training elements in their
working routine and to unintentionally blur TAU and
CAN Stop interventions, trainers of institutions, who
were selected into the control group will receive their
training for the CAN Stop training intervention only
after they completed t1 measurements in young canna-
bis users. Supervision protocols of CAN Stop trainers
for later qualitative analyses will be handled in a way
that no inference can be made about the respective
trainer.
Ethical considerations
All procedures are in concordance with the ethics com-
mittee of the Chamber of Physicians in all federal states
of Germany, in which the CAN Stop study takes place.
All participants of the study and - in the case of under-
age young cannabis users - their parents or official guar-
dians are informed about the study goals, procedures,
analyses and data reporting prior to participation. Only
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used for analyses. All young cannabis users of the con-
trol group are offered the CAN Stop training after their
data gathering is completed. In order to protect young
cannabis users’ identity to the study group personnel,
videographies of CAN Stop training sessions will be
made in a way that the camera is focused solely on the
CAN Stop trainer - so only voices of young cannabis
users are audible on videotapes.
Analysis
An intention-to-treat approach will be taken to analyze
data. Comparisons will be made between intervention
group and the TAU control group in the different set-
tings using baseline controlled ANCOVAs with cannabis
use and abstinence-oriented self-efficacy as dependent
variable and cannabis use at t0 as covariate. We plan to
perform nested analyses in order to handle the variance,
which is shared between participants attending the same
institution. There are no institutions, which offer more
than one CAN Stop training group, so a further layer of
nesting is not nescessary. We hypothesize that interven-
tion groups show lower levels of cannabis use and
higher levels of self-efficacy related to cannabis-
abstinence after the intervention as compared to con-
trols. To discover these effects, we calculated the needed
sample size of n = 119, assuming a medium effect size
of f = 0.25, given the power of the statistical test to .80
and setting the a-error on .05. Prior experience with the
target group have shown that attrition rates among
young cannabis users are rather high, so we calculated
with an attrition rate of 50% when planning the number
of nescessary participants at t0. With regard to further
effects, we believe there are differences in the effective-
ness of the training in the different settings. We
hypothesize that the effect of the training (d) will be
greater when less other interventions take place in the
respective setting, that is, effects are bigger in juvenile
prisons and out-patient institutions than in in-patient
setting clinics.
Secondary analyses will be made to compare the clien-
tele of the different settings. Here we assume that more
aggravated and chronic cannabis users will be found in
prisons and in-patient settings than in out-patient set-
tings. As for the role forced access to the group (e.g.
because of pressure from juidical institutions or tea-
chers) plays, we believe no differences will be seen
between participants, who indicated, they were attending
Table 1 Measures for young cannabis users
Target variable Measure Point of
measurement
Sociodemographics Living situation Social network Problems
with school, police, debts... Education Prior counselling and
therapies
pre, follow-up
Screening for acute psychosis Subscale of the Diagnostisches Interview psychischer Störungen
(DIPS; Diagnostic Interview of psychiatric disorders) [26]
pre
Substance use history Following the assessment standards III of the DG-Sucht (German
Society for Addiction Research and Therapy)
pre, post,
follow-up
Severity of dependence Severity of dependence scale (SDS) [27] pre, post,
follow-up
Psychosocial adjustment Youth self report (participants aged 14-17) [28] Young adult self
report (Participants aged 18-21) [29]
pre, post,
follow-up
Expected positive and negative effects of cannabis use Comprehensive Cannabis Expectancy Questionnaire (CCEQ) [30] pre, post,
follow-up
Relationship to friends and peers Questionnaire for health-related quality of life (Kiddo-KINDL revised,
subscale “friends”) [31]
pre, post,
follow-up
Family relationships Familienbogen/Selbstbeurteilungsbogen (family inventory, self-rating)
[32]
pre
Motivation for change in cannabis use Fragebogen zur Erfassung der Veränderungsbereitschaft (FEVER;
Questionnaire to protocol the willingness for change) [33,34]
pre, post,
follow-up
Personal goals with regard to changes in substance use Zielskala [35] pre, post,
follow-up
Self-efficacy with regard to cannabis abstinence or limited
cannabis use
Heidelberger Skalen zur Abstinenz-/Kontrollzuversicht (HEISA-16/HEIS-
KOTZ-12; Heidelberg scales of confidence regarding abstinence/
controlled use) [35]
pre, post,
follow-up
Satisfaction with the training Fragebogen zur Beurteilung der Behandlung, Version Patient (FBB-P;
Questionnaire for the satisfaction with treatment, patient version)
with minor adaptations [36]
post
Peer resistance regarding cannabis use own development pre, post,
follow-up
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as compared to participants, who decided to attend the
group solely on their own accord. This is, because we
assume the CAN Stop training itself is shaped in a way
as to leave decisions about further consume open to
participants, which inspires the internal motivation of all
participants and therefore blurs differences regarding
forced access to the training.
In order to gain insight into the training’s utility in the
different settings, qualitative and quantitative feedback
data from trainers will be synthesized and discussed
with clinical experts from different settings for triangu-
lation. Conclusions from this discussion process will be
shown to trainers in order to test the plausibility of our
conclusions to trainers and to check whether they feel
their experiences are sufficiently mirrored in the
conclusions.
Discussion
In this paper, we describe the study design of an innova-
tive training targeting young cannabis users in rather
different settings, which are very differently organised
but at the same time all share the goal to reduce their
clientele’s prior cannabis use. We are especially inter-
ested in how the different institutions will be able to
implement the training, what the differences between
their respective study participants are and how this is
mirrored in the effect(s) of the training. A special diffi-
culty of the study was to set up a study procedure
which matches the different frameworks of the respec-
tive setting, starting at the professional background of
the cooperation partners’ staff, their legal and organiza-
tional background and their different interests.
Several difficulties may arise when it comes to the
implementation of the study plan. First, it remains to be
seen, whether it is suitable to use the centralized study
telephone as a means to randomize young cannabis
users into different institutions, especially, when they
have already had contact to workers in one institution e.
g. through a personal talk when handing out the study
flyer, and they are assigned to another institution
because the respective group is available only there. It
remains to be seen, whether this potential switch marks
a problem for recruitment, because other institutions
are less easy to reach (e.g. with public transportation in
rural areas) or an attachment has already been formed
between one institution and a young cannabis user.
Another problem may arise through the referral of
young cannabis users to other institutions by the centra-
lized study hotline, because an institution, which may
already have established a first contact to a young can-
nabis user, could “loose” a potential client to another,
possibly competing institution and therefore may feel to
loose money usually granted to them when treating the
c l i e n t .W eh o p et h a tw ec a nc o n v i n c ea l lc o o p e r a t i o n
partners that statistically, the possibility to “loose” cli-
ents through the centralized telephone hotline is as high
as is the possibility to gain new clients because of the
same centralized referral of study participants.
If it turns out, that the procedure with regard to the
centralized telephone hotline poses a major threat to the
recruitment of study participants, we will discuss to
switch into a cluster randomized study design with
cooperating institutions as randomized subjects.
What may be another weakness of the study is the dif-
ferent dynamic of group - in our case the CAN Stop
training group - as opposed to individual treatment in
the case of individual TAUs. Groups may be terminated
if too many participants quit the group and therefore,
even participants, motivated to follow through the CAN
Stop training may be faced with a forced dismissal of
the intervention. This effect is not prevalent in indivi-
dual trainings and result in different attrition effects
between the intervention and the control group. More-
over, unspecific group effects of the training may not be
sufficiently controlled through this study design.
We take these weaknesses into account, however,
because we wanted to remain rather close to the every-
day working routine of our cooperation partners and a
rather pragmatic approach is nescessary to tackle the
problem of young cannabis users in a timely and eco-
nomic fashion.
We believe that it is nescessary to test specific inter-
vention effects in real-life as opposed to rather artificial
but, potentially methodologically more pure approaches.
Of course, we know about this characteristic of the
CAN Stop study and will take care of the mentioned
problems when analysing our data and discussing the
results.
Acknowledgements and Funding
The CAN Stop project is funded by the German Federal Ministry of Health,
by the German Centre for Addiction Research in Childhood and
Adolescence and by the University Medical Centre Rostock.
Author details
1German Centre for Addiction Research in Childhood and Adolescence
(DZSKJ), University Medical Centre Hamburg-Eppendorf, Martinistrasse 52,
20246 Hamburg, Germany.
2Clinic for Psychiatry, Neurology, Psychosomatics
and Psychotherapy in Children and Adolescents, University Medical Centre
Rostock, Gehlsheimer Strasse 20, 18147 Rostock, Germany.
Authors’ contributions
CB designed the study and its methodology, coordinates the study and
drafted the manuscript of this paper. AM, NW and KM participated in
designing the study and carry through its organizational processes and
cooperations. OR and RT conceived of the study, and participated in its
design and coordination. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Baldus et al. BMC Health Services Research 2011, 11:80
http://www.biomedcentral.com/1472-6963/11/80
Page 9 of 10Received: 8 December 2010 Accepted: 18 April 2011
Published: 18 April 2011
References
1. Bundeszentrale für gesundheitliche Aufklärung (BZgA): Die Drogenaffinität
Jugendlicher in der Bundesrepublik Deutschland Köln: BZgA; 2008.
2. Kuntsche E, Simons-Morton B, Fotiou A, ter Bogt T, Kokkevi A: Decrease in
Adolescent Cannabis Use From 2002 to 2006 and Links to Evenings Out
With Friends in 31 European and North American Countries and
Regions. Arch Pediatr Adolesc Med 2009, 163(2):119-125.
3. Best D, Gross S, Manning V, Gossop M, Witton J, Strang J: Cannabis use in
adolescents: the impact of risk and protective factors and social
functioning. Drug Alcohol Rev 2005, 24(6):483-488.
4. Flory K, Lynam D, Milich R, Leukefeld C, Clayton R: Early adolescent
through young adult alcohol and marijuana use trajectories: Early
predictors, young adult outcomes, and predictive utility. Dev
Psychopathol 2004, 16(1):193-213.
5. Windle M, Wiesner M: Trajectories of marijuana use from adolescence to
young adulthood: Predictors and outcomes. Dev Psychopathol 2004,
16(4):1007-1027.
6. Chassin L, Pitts SC, DeLucia C: The relation of adolescent substance use
to young adult autonomy, positive activity involvement, and perceived
competence. Dev Psychopathol 1999, 11(4):915-932.
7. Küstner U, Baldus C: Motivationsbehandlung eines Adoleszenten mit
einer substanzbedingten Störung. Psychotherapeut 2009, 54:205-210.
8. Budney AJ, Vandrey RG, Hughes JR, Thostenson JD, Bursac Z: Comparison
of cannabis and tobacco withdrawal: Severity and contribution to
relapse. J Subst Abus Treat 2008, 35(4):362-368.
9. Thomasius R, Weymann N, Stolle M, Petersen KU: Cannabiskonsum und
-missbrauch bei Jugendlichen und jungen Erwachsenen. Psychotherapeut
2009, 54:170-178.
10. Statistisches Bundesamt: Fachserie 13 Reihe 1.1 - Sozialleistungen, Angaben
zur Krankenversicherung (Ergebnisse des Mikrozensus) Wiesbaden: Statistisches
Bundesamt; 2008.
11. European Monotoring Centre for Drug and Drug Addiction (EMCDDA): A
cannabis reader: global issues and local experiences. Perspectives on cannabis
controversies treatment and regulation in Europe Lissabon: EMCDDA; 2008.
12. Simon R, Sonntag D: Cannabisbezogene Störungen: Umfang,
Behandlungsbedarf und Behandlungsangebot in Deutschland München: IFT-
Institut für Therapieforschung; 2004.
13. Bange D, Kristian S, Thiem M: Jugend- und Familienhilfe. In Suchtstörungen
im Kindes- und Jugendalter: Das Handbuch - Grundlagen und Praxis. Edited
by: Thomasius R, Schulte-Markwort M, Küstner UJ, Riedesser P. Stuttgart:
Schattauer; 2008:413-417.
14. Görgen W, Hartmann R: Expertise Zugang zu jungen
CannabiskonsumentInnen Münster: Landschaftsverband Westfalen-Lippe &
FOGS; 2006.
15. Hoch E, Zimmermann P, Noack R, Rohrbacher H, Pixa A, Henker J,
Dittmer K, Bühringer G, Wittchen HU: Manualisierte einzeltherapeutische
Behandlung problematischen Cannabiskonsums: Die “CANDIS"- Studie.
In Cannabismissbrauch und -abhängigkeit. Edited by: Thomasius R, Petersen
KU. Lengerich: Pabst; 2009:.
16. Liddle HA, Dakof GA, Parker K, Diamond GS, Barret K, Tejada M:
Multidimensional Family Therapy for adolescent substance abuse:
Results of a randomized clinical trail. Americam Journal of Drug & Alcohol
Abuse 2001, 27:651-687.
17. Hubrich R, Hüsler G, Minder W, Tossmann P: Realize it! Beratung bei
Cannabiskonsum. SuchtMagazin 2008, 3:34-38.
18. Görgen W, Hartmann R, Olivia H: Frühintervention bei erstauffälligen
Drogenkonsumenten (FreD) - Ergebnisse der wissenschaftlichen Begleitung
Köln: Gesellschaft für Forschung und Beratung im Gesundheits- und
Sozialbereich; 2003.
19. Tossmann P: Forschung und Praxis der Gesundheitsförderung, Band 31. Neue
Wege in der Prävention des Drogenkonsums - Onlineberatung am Beispiel von
drugcome.de Köln: BZgA; 2007.
20. Thiel A: Suchtprävention im Jugendstrafvollzug. In Suchtstörungen im
Kindes- und Jugendalter: Das Handbuch - Grundlagen und Praxis. Edited by:
Thomasius R, Schulte-Markwort M, Küstner UJ, Riedesser P. Stuttgart:
Schattauer; 2008:406-409.
21. Kriminologischer Dienst im Bildungsinstitut des niedersächsischen
Justizvollzugs: Drogenerfahrungen von Inhaftierten im niedersächsischen
Justizvollzug - Ergebnisse einer Zugangs- und Stichtagserhebung Celle:
Kriminologischer Dienst; 2006.
22. Köhler D: Psychische Störungen bei jungen Straftätern. Hamburg: Kovac;
2004.
23. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B,
Oxman AD, Moher D: Improving the reporting of pragmatic trials: an
extension of the CONSORT statement. Br Med J 2008, 337:12.
24. Miller WR, Rollnick S: Motivational Interviewing - preparing people for change
New York: The Guilford Press; 2002.
25. Rammstedt B, John OP: Measuring personality in one minute or less: A
10-item short version of the Big Five Inventory in English and German. J
Res Pers 2007, 41(1):203-212.
26. Schneider S, Marggraf J: Diagnostisches Interview psychischer Störungen - 3.
vollständig überarbeitete Auflage Heidelberg: Springer; 2005.
27. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J: The
Severity of Dependence Scale (Sds) - Psychometric Properties of the Sds
in English and Austrian Samples of Heroin, Cocaine and Amphetamine
Users. Addiction 1995, 90(5):607-614.
28. Arbeitsgruppe Deutsche Child Behaviour Checklist: Fragebogen für
jugendliche; deutsche Bearbeitung des Youth Self-Reports (YSR) der Child
Behaviour Checklist. Einführung und Anleitung zur Handauswertung. 2. Aufl.
mit deutschen Normen, bearbeitet von Döpfner M, Plück, J, Bölte, S, Lenz, K,
Melchers P, Heim, K Köln: Arbeitsgruppe Kinder-, Jugend- und
Familiendiagnostik (KJFD); 1998.
29. Achenbach TM: Manual for the Young Adult Self-Report and Young Adult
Behavior Checklist Burlington: University of Vermont Department of
Psychiatry; 1997.
30. Jäschke J: Cannabiswirkungserwartungen: Entwicklung des
Comprehensive Cannabis Expectancy Questionnaire (CCEQ). Münster:
Westfälische Wilhelms-Universität; 2006.
31. Ravens-Sieberer U: The revised KINDL-R. Final results on reliability,
validity and responsiveness of a modular HRQOL instrument for children
and adolescents. Quality of Life Research 2001, 10:199.
32. Cierpka M, Frevert G: Die Familienbögen. Ein Inventar zur Einschätzung von
Familienfunktionen. Handanweisung Göttingen: Hogrefe; 1994.
33. Hasler G, Klaghofer R, Buddeberg C: The University of Rhode Island
Change Assessment Scale (URICA) psychometric testing of a German
version. Psychother Psychosom Med Psychol 2003, 53(9-10):406-411.
34. Hasler G, R K, Buddeberg C: Der Fragebogen zur Erfassung der
Veränderungsbereitschaft (FEVER) - Testung der deutschen Version der
University of Rhode Island Change Assessment Scale (URICA). Psychother
Psychosom Med Psychol 2001, 53:406-411.
35. Körkel J, Schindler C, Hannig J: Die Heidelberger Skalen zur
Abstinenzzuversicht (HEISA). In Elektronisches Handbuch zu
Erhebungsinstrumenten im Suchtbereich (EHES). Volume 3.00. Edited by:
Glöcknier-Rist A, Rist F, Küfner H. Mannheim: Zentrum für Umfragen,
Methoden und Analysen; 2003:.
36. Mattejat F, Remschmidt H: Fragebogen zur Beurteilung der Behandlung (FBB).
Manual Göttingen: Hogrefe; 1999.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6963/11/80/prepub
doi:10.1186/1472-6963-11-80
Cite this article as: Baldus et al.: “CAN Stop” - Implementation and
evaluation of a secondary group prevention for adolescent and young
adult cannabis users in various contexts - study protocol. BMC Health
Services Research 2011 11:80.
Baldus et al. BMC Health Services Research 2011, 11:80
http://www.biomedcentral.com/1472-6963/11/80
Page 10 of 10